On 8/31/16 1:15 PM, Califbill wrote:
wrote:
On Wed, 31 Aug 2016 12:12:09 -0400, Keyser Soze
wrote:

I suggest you read for content and get back to us.

I read the "Canada" part and my first thought is I bet Canada might
ban exports to the US if this passes because it would make their
prices go up if they didn't. Their negotiations with the drug
companies will change if the companies realize this is not just the
small Canadian market but the much larger US market.
I don't think it is a secret that the US has always subsidized foreign
sales.


Most foreign countries regulate the price per manufacturing cost plus a
reasonable profit. They do not figure in development costs. Therefore the
USA consumer pays for all development costs.


The current scandal over the epipen price gouging has nothing to do with
development of the product or the cost of the med, which has been
estimated at no more than $1.00. Coincidentally, that is about the same
cost as the current polio vaccine. The original Salk vaccine costs to
the public were kept very low because Jonas Salk was a humanitarian, not
a corporate goniff, and if memory serves, did not patent his medication.
I remember distinctly as a little kid lining up at the local elementary
school, where doctors and nurses had volunteered to inoculate every
schoolkid in New Haven at no cost to parents.